首页 > 市场调查报告书 > 医疗设备

生技设备

一次性生物反应器市场规模、份额、成长分析（按产品类型、细胞类型、分子类型、应用、最终用途、使用类型和地区划分）—产业预测（2026-2033年）

市场调查报告书

商品编码

1904474

一次性生物反应器市场规模、份额、成长分析（按产品类型、细胞类型、分子类型、应用、最终用途、使用类型和地区划分）—产业预测（2026-2033年）

Single Use Bioreactors Market Size, Share, and Growth Analysis, By Product, By Type Of Cell, By Molecule Type, By Application, By End-Use, By Usage Type, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，一次性生物反应器市场规模将达到 38.7 亿美元，到 2025 年将成长至 45.3 亿美元，到 2033 年将成长至 161.2 亿美元，在预测期（2026-2033 年）内，复合年增长率为 17.19%。

一次性生物反应器（SUB）已成为细胞收集、培养、过滤、培养基製备和病毒灭活等环节不可或缺的工具，彻底改变了製药和临床领域。这些一次性系统采用伽马射线灭菌的聚乙烯和聚合物材料製成，透过最大限度地减少批次间的设定时间，显着简化了生物生产流程。人们对高效细胞储存和培养的日益关注正在推动市场成长。随着对先进疗法的需求不断增长，紧凑型桌上型一次性生物反应器因其简单性而备受青睐，减少了复杂的组装和灭菌程序，并加快了周转速度。此外，与传统的不銹钢生物反应器相比，一次性生物反应器通常具有更低的整体成本，从而在建造、运行和维护方面节省了大量成本，使其在生物製药的开发和优化中发挥着不可估量的作用。

一次性生物反应器市场驱动因素

生物製药需求的成长主要源自于人口老化导致各种疾病的增加，老年人更容易出现健康问题。为了因应这项人口结构变化，全球企业正加大对生物製药领域研发和生产流程的投入。此举旨在推动产品创新，提升产能，以满足不断成长的市场需求。因此，包括一次性生物反应器在内的生物加工技术的进步，在有效应对这些挑战方面发挥关键作用。

限制一次性生物反应器市场的因素

一次性生物反应器市场面临的主要挑战之一是缺乏可靠、精确且经济高效的感测器，以满足一次性生物反应器（SUB）的特定需求。为了在确保物料无菌的同时维持系统效率，整合到SUB中的感测器必须与现有平台完全相容。以往，在SUB系统中安装感测器往往会影响产品质量，凸显了开发先进感测器技术的必要性，这些技术既能满足SUB的运作需求，又不影响输出完整性。这项限制阻碍了SUB在各种应用中的整体有效性和广泛应用。

一次性生物反应器市场趋势

一次性生物反应器（SUB）市场在生物加工领域正经历显着成长，这主要得益于市场对灵活且扩充性的生产解决方案日益增长的需求。 SUB的诸多优势，例如降低时间成本、提高营运效率以及减少交叉污染风险，是推动这一趋势的关键因素。此外，随着生物製药公司寻求在降低营运成本的同时提高生产效率，SUB的吸引力也日益增强。这一市场的持续扩张反映了生物加工技术向创新技术的广泛转变，这些技术能够满足现代生产环境的需求，并将SUB定位为生物技术未来发展的关键组成部分。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Danaher（USA）
Sartorius AG（Germany）
Thermo Fisher Scientific（USA）
Merck KGaA（Germany）
Pall Corporation（USA）
Eppendorf SE（Germany）
ABEC（USA）
Celltainer（Netherlands）
Distek, Inc.（USA）
OmniBRx Biotechnologies（India）
PBS Biotech, Inc.（USA）
GE Healthcare（USA）
Cellexus Ltd.（UK）
Pierre Guerin（France）
CerCell ApS（Denmark）
Bioengineering AG（Switzerland）
Meissner Filtration Products（USA）
Kuhner Shaker（Switzerland）
Thermo Fisher Scientific（USA）

结论与建议

简介目录

Product Code: SQMIG35H2227

Single Use Bioreactors Market size was valued at USD 3.87 Billion in 2024 and is poised to grow from USD 4.53 Billion in 2025 to USD 16.12 Billion by 2033, growing at a CAGR of 17.19% during the forecast period (2026-2033).

Single-use bioreactors (SUBs) have transformed the pharmaceutical and clinical sectors, serving as essential tools for cell harvesting, culturing, filtration, media preparation, and virus inactivation. Constructed from gamma-sterilized polyethylene and polymer materials, these disposable systems significantly streamline the bioproduction process by minimizing preparation time between batches. The growing emphasis on efficient cell storage and cultivation is propelling market growth. As the demand for advanced therapeutics rises, smaller bench-top SUBs are favored for their simplicity, reducing the need for complex assembly and sterilization procedures, thus enhancing turnaround times. Additionally, SUBs often entail lower overall costs compared to traditional stainless-steel bioreactors, facilitating their widespread adoption by offering substantial savings in construction, operation, and maintenance, making them invaluable in biopharmaceutical development and optimization.

Top-down and bottom-up approaches were used to estimate and validate the size of the Single Use Bioreactors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Single Use Bioreactors Market Segments Analysis

Global Single Use Bioreactors Market is segmented by product, type of cell, molecule type, application, end-use, usage type and region. Based on product, the market is segmented into single-use bioreactor systems, single-use media bags, single-use assemblies and other related products. Based on type of cell, the market is segmented into mammalian cells, bacterial cells, yeast cells and other cells. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and other molecules. Based on application, the market is segmented into research and development, process development and bioproduction. Based on end-use, the market is segmented into pharmaceutical and biopharmaceutical companies, academic and research institutes, contract research organizations (CROs) and contract manufacturing organizations (CMOs). Based on usage type, the market is segmented into lab-scale production, pilot-scale production and large-scale production. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Single Use Bioreactors Market

The escalating demand for biopharmaceuticals is largely driven by the increasing prevalence of various diseases among the aging population, who are more vulnerable to health issues. In response to this shifting demographic landscape, companies worldwide are intensifying their focus on research and development, as well as manufacturing processes within the biopharmaceutical sector. This heightened emphasis aims to facilitate product innovation and enhance production capabilities to meet the growing needs of the market. As a result, the evolution of bioprocessing technologies, including single-use bioreactors, plays a crucial role in addressing these challenges effectively.

Restraints in the Single Use Bioreactors Market

A significant challenge facing the Single Use Bioreactors market is the absence of reliable, precise, and cost-effective sensors that cater to the specific requirements of Single Use Bioreactors (SUBs). Maintaining system efficiency while ensuring the sterility of materials necessitates that the sensors integrated into SUBs are fully compatible with existing platforms. Historically, the installation of sensors within SUB systems has led to diminished product quality, highlighting the critical need for advanced sensor technology that aligns with the operational demands of SUBs without compromising output integrity. This limitation hampers the overall effectiveness and adoption of SUBs in various applications.

Market Trends of the Single Use Bioreactors Market

The Single Use Bioreactors (SUBs) market is experiencing a significant surge in adoption within the bioprocessing sector, driven by the increasing need for flexible and scalable production solutions. This trend is fueled by the advantages that SUBs offer, including reduced time costs, streamlined operations, and diminished risk of cross-contamination. Additionally, as biopharmaceutical companies seek to enhance productivity and efficiency while minimizing overhead costs, the appeal of SUBs continues to grow. This ongoing market expansion reflects a broader shift towards innovative bioprocessing technologies that meet the demands of modern manufacturing environments, positioning SUBs as a vital component in the future of biotechnology.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Single Use Bioreactors Market Size by Product & CAGR (2026-2033)

Market Overview
Single-Use Bioreactor Systems
- Stirred Tank
- Wave-Mixed
- Bubble Column
Single-Use Media Bags
Single-Use Assemblies
Other Related Products

Global Single Use Bioreactors Market Size by Type Of Cell & CAGR (2026-2033)

Market Overview
Mammalian Cells
Bacterial Cells
Yeast Cells
Other Cells

Global Single Use Bioreactors Market Size by Molecule Type & CAGR (2026-2033)

Market Overview
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Stem Cells
Gene Therapy
Other Molecules

Global Single Use Bioreactors Market Size by Application & CAGR (2026-2033)

Market Overview
Research And Development
Process Development
Bioproduction

Global Single Use Bioreactors Market Size by End-Use & CAGR (2026-2033)

Market Overview
Pharmaceutical And Biopharmaceutical Companies
Academic And Research Institutes
Contract Research Organizations (CROs)
Contract Manufacturing Organizations (CMOs)

Global Single Use Bioreactors Market Size by Usage Type & CAGR (2026-2033)

Market Overview
Lab-Scale Production
Pilot-Scale Production
Large-Scale Production

Global Single Use Bioreactors Market Size & CAGR (2026-2033)

North America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- USA
- Canada
Europe (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Type Of Cell, Molecule Type, Application, End-Use, Usage Type)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Danaher (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pall Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ABEC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltainer (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Distek, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OmniBRx Biotechnologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PBS Biotech, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellexus Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pierre Guerin (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CerCell ApS (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioengineering AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meissner Filtration Products (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kuhner Shaker (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments